Emma Bishop is a Senior Scientist specializing in immunotoxicology at ApconiX since 2025. Previously, they worked as a Scientist at Redx Pharma from 2023 to 2025, where they developed in vitro assays to evaluate small molecule inhibitors for cancer. Emma completed a PhD in Immunology at the University of Birmingham from 2018 to 2023, during which they identified a novel role for the inflammatory cytokine TNF-α in CD4+ T cell metabolism and function related to rheumatoid arthritis. They also gained experience as a Visiting Researcher at the University of Calgary in 2019. Emma earned a Bachelor of Science with Honours in Biomedical Sciences from the University of Birmingham in 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices